Treasury Board of Canada Secretariat
www.tbs-sct.gc.ca
Common menu bar links
Breadcrumb Trail
ARCHIVED - Patented Medicine Prices Review Board Canada
This page has been archived.
Archived Content
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Table of Contents
Management Representation Statement
Overall Departmental Performance
- Mandate and Jurisdiction
- Issues, Trends and Challenges
- Performance Highlights
- Sales, Prices and R&D Trends
SECTION II - ANALYSIS OF THE PROGRAM ACTIVITY BY STRATEGIC OUTCOME
Priority 1: Compliance and Enforcement
- Price Reviews
- Enforcement Measures
- Amendments to the Patented Medicines Regulations
- Review of the Board's Excessive Price Guidelines
Priority 2: Report on Pharmaceutical Trends
- Price Trends
- Utilization of Patented Drugs
- Canadian Sales in the Global Context
- Analysis of Research and Development Expenditures
- Analytical Studies of Pharmaceutical Trends
SECTION III - SUPPLEMENTARY INFORMATION
Financial Table 1: Comparison of Planned to Actual Spending (including FTEs)
Financial Table 2: Voted and Statutory Items
Financial Table 3: Sources of Non-Respendable Revenue
Financial Table 4: Financial Statements of the Patented Medicine Prices Review Board
SECTION IV - OTHER ITEMS OF INTEREST
